Navigation Links
LipiVage™ Fat Harvest, Wash & Transfer System

ProductsLipiVage™ Fat Harvest, Wash & Transfer System
Company Genesis Biosystems
Item LipiVage™ Fat Harvest, Wash & Transfer System
Features 
  • Sterile/Disposable device
  • Gentle low vacuum
  • No centrifuge required
  • Cleans fat during harvesting
  • Fat is immediatley ready for re-injection.
Description The LipiVage™ Fat Harvest, Wash & Transfer System is a patent-pending disposable, medical device created to make fat transfer procedures simpler for the physician and their staff, and to satisfy the need for an office-based technique. LipiVage™ improves upon traditional fat transfer methods. There is no longer a need to centrifuge, decant or expose fat cells to unnecessary handling. LipiVage™ provides the physician with a simple to use tool that helps to ensure a lasting result. LipiVage™ is gentle on cells, time saving, and simple to use.
Info Genesis Biosystems
Customer Service: (972) 315-7888
Web site: http://www.dermagenesis.com/

Related medicine products :

1. Trans-Blot SD Semi-Dry Electrophoretic Transfer Cell
2. Mini Trans-Blot Electrophoretic Transfer Cell
3. Thermal Transfer Wristbands
4. Transferrin (Liquid)
5. Transferrin
6. Beta-2 Transferrin
7. Carbohydrate Deficient Transferrin for Alcohol Use
8. Carbohydrate Deficient Transferrin for Congenital Glycosylation Disorders
9. Gamma Glutamyl Transferase, Serum or Plasma
10. Glycosylated Transferrin
11. Soluble Transferrin Receptor
(Date:3/28/2015)... March 28, 2015 Genomic medicine experts ... mesothelioma, revealing, for the first time, key information for ... to read the newly posted story on the ... University of British Columbia, the British Columbia Cancer Agency, ... to reveal underlying molecular alterations and mutations that can ...
(Date:3/28/2015)... Lately the student-athlete experience has ... proposals around the NCAA. In a March episode of ... across a spectrum of universities and sports shed light ... special panel consists of athletes who have competed for ... track and field, baseball, and volleyball. They discuss the ...
(Date:3/28/2015)... Mirada, CA (PRWEB) March 28, 2015 ... ear, nose and throat disorders, are now ... is a common issue which is characterized by the ... Affecting 1 in 5 people, tinnitus is a prevalent ... disorder and while it is non-fatal, tinnitus can impede ...
(Date:3/28/2015)... March 28, 2015 Designers and Professionals ... overlay entitled Scratches 5K from Pixel Film Studios. , ... to any media inside Final Cut Pro X” Said ... saves time and is an effective tool for any ... Overlay Scratches 5K's intuitive grunge overlays. Simply drag title ...
(Date:3/28/2015)... NY (PRWEB) March 28, 2015 ... of dietary supplements announces the release of their ... was shown in two randomized, double-blind, placebo-controlled clinical ... and waist and hip size. MuffinStop™ is a ... indicus and Garcinia mangostana, fused together to create ...
Breaking Medicine News(10 mins):Health News:New Genomics Research May Help Doctors Tailor Mesothelioma Treatment, According to Surviving Mesothelioma 2Health News:SCI TV Panel of Former College Athletes Discusses Student Athlete Experience 2Health News:SCI TV Panel of Former College Athletes Discusses Student Athlete Experience 3Health News:Healthpointe now Offering Tinnitus Treatments in Clinics throughout Southern California 2Health News:Pixel Film Studios Unveiled Scratches 5k for Final Cut Pro X Editors 2Health News:Purity Products Releases Revolutionary New Weight Loss Product, MuffinStop™ 2
... WASHINGTON, D.C., October 5, 2011 The Merck ... than $4 million in funding to implement the ... Symptoms (CHAMPS) partnership in five non-profit, Federally Qualified ... (CHC) is designed to demonstrate how asthma management ...
... (October 4, 2011)In a new study led by Fox ... have found that Gleason scores determined by pathologists at ... of recurrence than Gleason scores from referring institutions. ... Meeting of the American Society for Radiation Oncology on ...
... new study from the University of Adelaide shows the parents of ... some form of cardiovascular disease. PCOS is a hormonal disorder ... one of the most common endocrine disorders in women and a ... with PCOS are more likely to have any form of cardiovascular ...
... HealthDay Reporter , TUESDAY, Oct. 4 (HealthDay News) -- Heart ... just as well if they are released the same day as ... research shows. "[Discharging patients the same day] wasn,t associated ... lead author of a study appearing in the Oct. 5 issue ...
... Oct. 5 (HealthDay News) -- Three hours of vigorous exercise ... 22 percent, a new study suggests. The Harvard School ... of that decreased risk was due to the beneficial effects ... (HDL) cholesterol. The findings were published Oct. 4 the ...
... (HealthDay News) -- ,A common structural variation in the brain ... details of past events and to distinguish real events from ... report. The study included 53 healthy adults who underwent ... a fold at the front of the brain called the ...
Cached Medicine News:Health News:Childhood asthma non-profit invests millions in health centers to help children better manage asthma 2Health News:Childhood asthma non-profit invests millions in health centers to help children better manage asthma 3Health News:Fox Chase Gleason scores better predict prostate cancer's recurrence after radiation 2Health News:Fox Chase Gleason scores better predict prostate cancer's recurrence after radiation 3Health News:Overnight Stay May Not Be Necessary for Stenting: Study 2Health News:Overnight Stay May Not Be Necessary for Stenting: Study 3Health News:MRI Study Unfolds Clues to Memory 2
(Date:3/27/2015)... 2015  RXi Pharmaceuticals Corporation (NASDAQ: ... announced that they have entered into an ... proprietary sd-rxRNA® technology for use in developing ... the potential to result in novel, more ... could be a significant step toward personalized ...
(Date:3/27/2015)... 27, 2015  Delcath Systems, Inc. (NASDAQ: ... company focused on oncology with an emphasis on ... announces the reporting of data from a single ... Injection with the Delcath Hepatic Delivery System (Melphalan/HDS) ... the Society of Surgical Oncology (SSO) Annual Meeting ...
(Date:3/26/2015)... 2015  The Burzynski Research Institute, Inc. (BRI) announced ... by the Department of Surgery at Kurume University ... have been published. The study, a randomized non-blinded ... as post-operative adjuvant therapy with and without Antineoplastons ... A total of 65 patients, ...
Breaking Medicine Technology:RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 2RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 3RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 4RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 5Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 2Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 3Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 4Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 5